Cargando…

Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients

INTRODUCTION: The main factors that are involved in a correct adherence to the therapeutic recommendations in Bipolar Disorder includes aspects related to age, sex, ethnicity, socioeconomic level and characteristics of the illness associated with the severity, comorbidity and adverse effects related...

Descripción completa

Detalles Bibliográficos
Autores principales: Partera, J.Á. Alcalá, Navas, A. Fontalba, Morales, M. Company, Guillena, S.L. Romero, Higueras, T. Gutiérrez, Cortés, F. Calera, Forés, S. Vicent, Rojas, L. Gutiérrez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471582/
http://dx.doi.org/10.1192/j.eurpsy.2021.519
_version_ 1784789111178002432
author Partera, J.Á. Alcalá
Navas, A. Fontalba
Morales, M. Company
Guillena, S.L. Romero
Higueras, T. Gutiérrez
Cortés, F. Calera
Forés, S. Vicent
Rojas, L. Gutiérrez
author_facet Partera, J.Á. Alcalá
Navas, A. Fontalba
Morales, M. Company
Guillena, S.L. Romero
Higueras, T. Gutiérrez
Cortés, F. Calera
Forés, S. Vicent
Rojas, L. Gutiérrez
author_sort Partera, J.Á. Alcalá
collection PubMed
description INTRODUCTION: The main factors that are involved in a correct adherence to the therapeutic recommendations in Bipolar Disorder includes aspects related to age, sex, ethnicity, socioeconomic level and characteristics of the illness associated with the severity, comorbidity and adverse effects related to previous medicine. OBJECTIVES: To analyse the individual perception that the patient with Bipolar Disorder has regarding the positive and negative aspects of taking the recommended medication. METHODS: Descriptive and interpretative observational study under the qualitative paradigm of research, extracting the data through the completion of four focus groups with ten patients everyone. To complete the codification of the content of the participant’s discourses, we rely on the QRS NVivo 10 computer program. RESULTS: In the participant’s discourse concerning the main barriers to pharmacological treatment, for example “It’s because we live in a society and, because of that, we don’t go without medicine; if we didn’t live in society, we wouldn’t take medicine because we wouldn’t bother anyone”. Some examples of patient’s discourse, about perceived facilitators were: “I have to take medicine for my bipolar disorder, that’s it, I have a treatment, my illness has a name”. CONCLUSIONS: The main facilitators regarding the use of pharmacological treatment in Bipolar Disorder are the perceived need for treatment in the acute phase and the recognition of the illness, the shared clinical decision and the causal biological attribution in the chronic phase. About perceived barriers, social control is identified in both phases, adverse effects in the acute cases and the absence of effective treatment in the chronic state.
format Online
Article
Text
id pubmed-9471582
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94715822022-09-29 Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients Partera, J.Á. Alcalá Navas, A. Fontalba Morales, M. Company Guillena, S.L. Romero Higueras, T. Gutiérrez Cortés, F. Calera Forés, S. Vicent Rojas, L. Gutiérrez Eur Psychiatry Abstract INTRODUCTION: The main factors that are involved in a correct adherence to the therapeutic recommendations in Bipolar Disorder includes aspects related to age, sex, ethnicity, socioeconomic level and characteristics of the illness associated with the severity, comorbidity and adverse effects related to previous medicine. OBJECTIVES: To analyse the individual perception that the patient with Bipolar Disorder has regarding the positive and negative aspects of taking the recommended medication. METHODS: Descriptive and interpretative observational study under the qualitative paradigm of research, extracting the data through the completion of four focus groups with ten patients everyone. To complete the codification of the content of the participant’s discourses, we rely on the QRS NVivo 10 computer program. RESULTS: In the participant’s discourse concerning the main barriers to pharmacological treatment, for example “It’s because we live in a society and, because of that, we don’t go without medicine; if we didn’t live in society, we wouldn’t take medicine because we wouldn’t bother anyone”. Some examples of patient’s discourse, about perceived facilitators were: “I have to take medicine for my bipolar disorder, that’s it, I have a treatment, my illness has a name”. CONCLUSIONS: The main facilitators regarding the use of pharmacological treatment in Bipolar Disorder are the perceived need for treatment in the acute phase and the recognition of the illness, the shared clinical decision and the causal biological attribution in the chronic phase. About perceived barriers, social control is identified in both phases, adverse effects in the acute cases and the absence of effective treatment in the chronic state. Cambridge University Press 2021-08-13 /pmc/articles/PMC9471582/ http://dx.doi.org/10.1192/j.eurpsy.2021.519 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Partera, J.Á. Alcalá
Navas, A. Fontalba
Morales, M. Company
Guillena, S.L. Romero
Higueras, T. Gutiérrez
Cortés, F. Calera
Forés, S. Vicent
Rojas, L. Gutiérrez
Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients
title Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients
title_full Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients
title_fullStr Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients
title_full_unstemmed Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients
title_short Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients
title_sort barriers and facilitators associated with pharmacological treatment in bipolar disorder patients
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471582/
http://dx.doi.org/10.1192/j.eurpsy.2021.519
work_keys_str_mv AT parterajaalcala barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients
AT navasafontalba barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients
AT moralesmcompany barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients
AT guillenaslromero barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients
AT higuerastgutierrez barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients
AT cortesfcalera barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients
AT foressvicent barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients
AT rojaslgutierrez barriersandfacilitatorsassociatedwithpharmacologicaltreatmentinbipolardisorderpatients